THIS, a UK food tech startup that produces plant-based meat alternatives secures €5.1M funding
UK-based THIS is one of the fastest-growing food businesses with a growth rate of 53% month-on-month.
Popular topics
Where the capital lands, who writes the cheque, and what gets built with it. Funding rounds, venture capital flows, and the deal-making that shapes which technology companies scale.
6,932 articles · Funding
UK-based THIS is one of the fastest-growing food businesses with a growth rate of 53% month-on-month.
Israel-based travel booking startup Pruvo recently closed $1.1M (€1.03 million approx.) in its seed funding round despite the tremendous impact Coronavirus has had on the travel industry.
Belgium video technology startup THEO Technologies has announced that it raised $10 million (approx €9.3 million) in a Series A funding round led by SmartFin Capital with participation from PMV and Media Invest Vlaanderen (MIV).
Oddbox, London's first wonky fruit, and veg box subscription scheme has raised €3.2 million from the Northern Venture Capital Trust (VCT) Funds, which are managed by Mercia.
UNL is an Amsterdam and Singapore-based smart addressing platform for location and navigation services.
Smart rings are in the nascent stage right now in the wearable market segment.
Amsterdam-based fintech startup Factris provides an online invoice factoring platform for European SMEs.
The German fintech platform for business banking, Penta has just announced to have raised €18.5 million in the first closing of a new…
Refurbed, the marketplace for refurbished electronics promoting sustainable consumption, has raised $17 million (approx €15.5 million) in Series A round of equity financing from a group of reputable international investors.
Based out of Northampton, UK, an e-commerce fulfilment platform and service, James and James Fulfilment has secured an £11 million (approx €12 million) in an attempt to enhance its market-leading, software-enabled e-fulfilment proposition.
Toxys is a Dutch biotech startup offering a broad spectrum of innovative in vitro toxicology solutions.
Harbour BioMed, a Cambridge, MA- Rotterdam, The Netherlands and Suzhou, China-based global, clinical-stage biopharmaceutical company, closed a $75 million (€67.4 million approx) Series B+ round of financing.